CHPA issues statement on HHS/FDA plans to phase out some synthetic dyes
The FDA and HHS have announced plans to phase out petroleum-based synthetic dyes from the national food supply and replace them with natural ingredients.
CHPA
Health In Hand Foundation calls for nominations for 2025 U.S. Self-Care Marketing Awards
The awards honor strategic innovation and marketing in OTC medicine, dietary supplements, and OTC medical devices.
CHPA releases statement on FDA plans to end animal testing
“We look forward to working collaboratively with FDA and other stakeholders on this important scientific and regulatory paradigm shift,” says the CHPA.
CHPA lauds lawmakers for urging FDA to safeguard Rx-OTC pathway
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
Industry groups issue statements on confirmation of Dr. Makary as FDA commissioner
The Senate confirmed Dr. Makary's nomination by a vote of 56-44.
Greg Bradley elected CHPA board chair
Bradley is the president and CEO of Foundation Consumer Healthcare and has been a standing member of CHPA’s board of directors.
Chris DeWolf receives Ivan D. Combe Lifetime Achievement Award
DeWolf, a transformative figure in the industry, received the award, the highest honor in the U.S. consumer healthcare sector, for decades of dedication and service.
Health In Hand Foundation announces 2024 U.S. Self-Care Marketing Award Winners at Annual Gala
The event program also included the announcement of the foundation’s new board member, Mark Pearson, Reckitt’s vice president of Marketing Health.
CHPA pushes back on FDA proposal to reverse oral phenylephrine's OTC status
The proposed order challenges FDA’s longstanding recognition of PE as a safe and effective treatment for nasal congestion.